This open label, two period, crossover study will evaluate the safety and the effect of food on the pharmacokinetics of RO5428029 in healthy volunteers. In a crossover design, healthy subjects will be randomized to receive a single oral dose of RO5428029 with or without food, with a washout period of at least 7 days between dosing and a follow-up of 7 to 10 days after last dose. Anticipated time on study will be up to 21 days.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Enrollment
12
Single oral dose
Unnamed facility
San Antonio, Texas, United States
Effect of food on pharmacokinetics (plasma concentrations) of RO5428029 following oral administration
Time frame: 72 hours
Safety: Incidence of adverse events
Time frame: approximately 3 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.